Cyrano Therapeutics is a private, venture-backed clinical stage regenerative medicine company developing a novel therapy to restore smell and flavor function. The chronic loss of smell and flavor is a condition affecting at least 5% of the U.S. population with a similar incidence in Europe and Asia. Influenza, allergic rhinitis and traumatic brain injury are commonly known causes of chronic smell and flavor loss. The condition is now recognized as a widely prevalent long-term condition experienced by many patients who have recovered from COVID-19.
Rick co-founded Cyrano Therapeutics after he encountered a sudden and almost complete smell and flavor loss due to the flu. Shortly thereafter Rick discovered the work of Dr. Robert Henkin, and partnered with him to develop a simple nasal spray with the potential to restore smell/flavor in the millions of people who have lost it.Read More
Founder and Director of The Taste and Smell Clinic, Washington DC, Dr. Henkin has spent the last 40 years devoted to the advancement of the diagnosis and treatment of taste and smell disorders as evidenced by over 1000 peer reviewed publications on the subject. Prior to the Taste and Smell Clinic, Dr. Henkin was a scientist at the NIH and a Professor at Georgetown University.
Ron Kuppersmith, MD, MBA, FACS, practices in College Station, Texas and is a Professor of Surgery at the Texas A&M Health Science Center College of Medicine. He has previously served as President of the American Academy of Otolaryngology-Head and Neck Surgery and President of the Texas Association of Otolaryngology.
Former FDA reviewer (6 years), over 30 years of experience in pharma, with over 10 years of regulatory drug development experience in working with Central Nervous System compounds.
At Cyrano Therapeutics, we are committed to developing a proven therapy for long-term smell and flavor loss. For more information about joining our future clinical trials please contact us.